GSK takes USD300 million stake in 23andMe

26 July 2018 - Deborah Wilkes

Archived

GlaxoSmithKline has announced a four-year collaboration with 23andMe, and is taking a USD300 million stake in the privately-held consumer genetics and research company.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: